Literature DB >> 15321737

Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats.

Yoshihide Fujisawa1, Yukiko Nagai, Akira Miyatake, Yoshio Takei, Katsuyuki Miura, Takatomi Shoukouji, Akira Nishiyama, Shouji Kimura, Youichi Abe.   

Abstract

A new member of the adrenomedullin family, adrenomedullin2, was identified in mammals. The effects of adrenomedullin2 on renal hemodynamics and urine formation were examined in rats. Intrarenal arterial infusion of adrenomedullin2 at rates of 30, 100 and 300 pmol/kg/min decreased blood pressure and increased heart rate in a dose-dependent fashion. Adrenomedullin2 infusion at 100 pmol/kg/min significantly increased renal blood flow and urine flow. At the higher infusion rate (300 pmol/kg/min), adrenomedullin2 significantly decreased urine flow. Continuous intrarenal infusion of adrenomedullin2 at 100 pmol/kg/min significantly increased renal blood flow from 6.7+/-0.5 to 8.8+/-0.5 ml/min and decreased renal vascular resistance from 16+/-1 to 11+/-1 mm Hg min/ml. Urine flow was significantly increased from 21.5+/-4.9 to 36.2+/-8.5 microl/min and urinary excretion of sodium was increased from 2.3+/-0.9 to 4.9+/-1.4 microEq/min. Blood pressure, heart rate and glomerular filtration rate did not change. Infusion of a similar dose of adrenomedullin also increased renal blood flow (6.8+/-0.4-8.8+/-0.6 ml/min), urine flow (25.4+/-3.2-42.8+/-9.4 microl/min) and urinary excretion of sodium (2.8+/-0.6-6.5+/-1.2 microEq/min), decreased renal vascular resistance (15+/-1-11+/-1 mm Hg min/ml) and did not alter glomerular filtration rate. Thus, the renal actions induced by adrenomedullin2 were similar to those of adrenomedullin. These data suggest that adrenomedullin2 may play an important role in the regulation of renal hemodynamics and urine formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15321737     DOI: 10.1016/j.ejphar.2004.06.039

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Intermedin and the unfolded protein response.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2011-12       Impact factor: 4.599

Review 2.  Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Authors:  Song-Yang Zhang; Ming-Jiang Xu; Xian Wang
Journal:  Br J Pharmacol       Date:  2017-05-16       Impact factor: 8.739

3.  Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats.

Authors:  Aly M Abdelrahman; Catherine C Y Pang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-31       Impact factor: 3.000

Review 4.  Genetics of salt-sensitive hypertension.

Authors:  Hironobu Sanada; John E Jones; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2011-02       Impact factor: 5.369

Review 5.  The pharmacology of adrenomedullin 2/intermedin.

Authors:  Yanguo Hong; Debbie L Hay; Remi Quirion; David R Poyner
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Intermedin is a new angiogenic growth factor.

Authors:  Robert S Smith; Lin Gao; Grant Bledsoe; Lee Chao; Julie Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-10       Impact factor: 4.733

7.  Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.

Authors:  Yuying Liu; Grant Bledsoe; Makato Hagiwara; Zhi-Rong Yang; Bo Shen; Lee Chao; Julie Chao
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-20

8.  Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress.

Authors:  Makoto Hagiwara; Grant Bledsoe; Zhi-Rong Yang; Robert S Smith; Lee Chao; Julie Chao
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-01

Review 9.  Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.

Authors:  D Bell; B J McDermott
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

10.  Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats.

Authors:  L Jolly; J E March; P A Kemp; T Bennett; S M Gardiner
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.